JPWO2022060973A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022060973A5 JPWO2022060973A5 JP2023517268A JP2023517268A JPWO2022060973A5 JP WO2022060973 A5 JPWO2022060973 A5 JP WO2022060973A5 JP 2023517268 A JP2023517268 A JP 2023517268A JP 2023517268 A JP2023517268 A JP 2023517268A JP WO2022060973 A5 JPWO2022060973 A5 JP WO2022060973A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharma
- stereoisomer
- acceptable salt
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063079217P | 2020-09-16 | 2020-09-16 | |
| US63/079,217 | 2020-09-16 | ||
| PCT/US2021/050649 WO2022060973A1 (en) | 2020-09-16 | 2021-09-16 | Tyk2 inhibitors and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023541203A JP2023541203A (ja) | 2023-09-28 |
| JP2023541203A5 JP2023541203A5 (https=) | 2024-09-17 |
| JPWO2022060973A5 true JPWO2022060973A5 (https=) | 2024-09-17 |
| JP7824938B2 JP7824938B2 (ja) | 2026-03-05 |
Family
ID=78086111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517268A Active JP7824938B2 (ja) | 2020-09-16 | 2021-09-16 | Ｔｙｋ２阻害剤およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230357273A1 (https=) |
| EP (1) | EP4214215A1 (https=) |
| JP (1) | JP7824938B2 (https=) |
| KR (1) | KR20230069984A (https=) |
| CN (1) | CN117279922B (https=) |
| AU (1) | AU2021345181A1 (https=) |
| CA (1) | CA3192621A1 (https=) |
| IL (1) | IL301385A (https=) |
| WO (1) | WO2022060973A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024539280A (ja) | 2021-10-25 | 2024-10-28 | カイメラ セラピューティクス， インコーポレイテッド | Ｔｙｋ２分解剤およびそれらの使用 |
| JP2025509596A (ja) * | 2022-03-16 | 2025-04-11 | アルミス インコーポレイテッド | Ｔｙｋ２阻害剤およびその使用 |
| WO2023178235A1 (en) * | 2022-03-16 | 2023-09-21 | Alumis Inc. | Tyk2 inhibitors and uses thereof |
| WO2023208244A1 (zh) * | 2022-04-29 | 2023-11-02 | 南京明德新药研发有限公司 | 大环类化合物及其应用 |
| WO2024199479A1 (zh) | 2023-03-31 | 2024-10-03 | 北京普祺医药科技股份有限公司 | 一种大环化合物、药物组合物及其用途 |
| WO2024222807A1 (en) * | 2023-04-27 | 2024-10-31 | Hangzhou Highlightll Pharmaceutical Co., Ltd | Novel macrocyclic heteroaryl derivatives as kinase inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2864839T3 (es) * | 2015-07-02 | 2021-10-14 | Turning Point Therapeutics Inc | Macrociclos de diarilo quirales como moduladores de proteína quinasas |
| US10479793B2 (en) * | 2015-11-18 | 2019-11-19 | Bristol-Myers Squibb Company | Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses |
| ES2902995T3 (es) * | 2016-10-07 | 2022-03-30 | Bristol Myers Squibb Co | Compuestos de imidazopiridazina útiles como moduladores de respuestas a IL-12, IL-23 y/o IFN alfa |
| TWI808958B (zh) * | 2017-01-25 | 2023-07-21 | 美商特普醫葯公司 | 涉及二芳基巨環化合物之組合療法 |
| CN120865208A (zh) * | 2019-01-23 | 2025-10-31 | 武田药品工业株式会社 | Tyk2抑制剂和其用途 |
| US20220135567A1 (en) * | 2019-02-07 | 2022-05-05 | Ventyx Biosciences, Inc. | Tyk2 pseudokinase ligands |
| CA3132632A1 (en) * | 2019-03-11 | 2020-09-17 | Esker Therapeutics, Inc. | Tyk2 inhibitors and uses thereof |
| AU2020247990A1 (en) * | 2019-03-26 | 2021-11-11 | Ventyx Biosciences, Inc. | TYK2 pseudokinase ligands |
-
2021
- 2021-09-16 AU AU2021345181A patent/AU2021345181A1/en active Pending
- 2021-09-16 JP JP2023517268A patent/JP7824938B2/ja active Active
- 2021-09-16 IL IL301385A patent/IL301385A/en unknown
- 2021-09-16 WO PCT/US2021/050649 patent/WO2022060973A1/en not_active Ceased
- 2021-09-16 US US18/026,309 patent/US20230357273A1/en active Pending
- 2021-09-16 CA CA3192621A patent/CA3192621A1/en active Pending
- 2021-09-16 KR KR1020237012767A patent/KR20230069984A/ko active Pending
- 2021-09-16 EP EP21789976.4A patent/EP4214215A1/en active Pending
- 2021-09-16 CN CN202180076687.5A patent/CN117279922B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3980400B1 (en) | Peptidomimetics for the treatment of coronavirus and picornavirus infections | |
| JP4884219B2 (ja) | ピリジル誘導体および治療剤としてのその用途 | |
| EP1027050B1 (en) | 1,3-thiazoles as adenosine a3 receptor antagonists for the treatment of allergy, asthma and diabetes | |
| JP4838128B2 (ja) | ピペラジン誘導体および治療剤としてのその用途 | |
| CN101516877B (zh) | 杂环有机化合物 | |
| AU2018340376B2 (en) | Substituted pyrimidine piperazine compound and use thereof | |
| JP2008505891A (ja) | 治療薬としてのニコチンアミド誘導体およびそれらの使用 | |
| TW202016073A (zh) | B型肝炎蛋白殼組裝調節劑 | |
| US20090197894A1 (en) | Nicotinamide derivatives and their use as therapeutic agents | |
| JP2019527731A (ja) | Ｈｂｖ感染の治療のための新規治療薬 | |
| JPH07503018A (ja) | ピリジル置換イミダゾール | |
| RU2007118687A (ru) | Триазолы, используемые в качестве ингибиторов протеинкиназ | |
| RU2007124329A (ru) | ПРОИЗВОДНЫЕ 5-ГИДРОКСИБЕНЗОТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ β2 АДРЕНОРЕЦЕПТОРОВ | |
| JP2023085345A (ja) | グリコシド化合物の誘導体からなる血管新生促進薬物を含有する予防薬 | |
| TW201700098A (zh) | 治療ｂ型肝炎病毒的方法 | |
| BR112021000938A2 (pt) | composto sal farmaceuticamente aceitável, tautômero, isômero ou estereoisômero do mesmo, composição farmacêutica e processo para a síntese do dito composto | |
| RU2009149518A (ru) | Триазоло[1, 5-а]хинолины в качестве лигандов рецептора аденозина а3 | |
| JPWO2022060973A5 (https=) | ||
| JP5793182B2 (ja) | Ｃｃｒ１受容体アンタゴニストとしてのアザインダゾールアミド化合物 | |
| JP2022519764A (ja) | 二環式スルホンアミド | |
| AU759604B2 (en) | Inhibitor for 20-hete-yielding enzyme | |
| CN1177824C (zh) | 羟基甲脒衍生物及含有该衍生物的药物 | |
| ES2963508T3 (es) | Derivados de 5-hidroxi-7-oxabiciclo[2.2.1]heptano-2-carboxamida para inducir condrogénesis para el tratamiento del daño articular | |
| CN121039124A (zh) | 一种杂环化合物及其在医药上的应用 | |
| EP4649086A1 (en) | Protease inhibitors for treating or preventing coronavirus infection |